The Endo Fails Continue - Uther

Status
Not open for further replies.

5byfive

GLP-1 Enthusiast
Chief Expert
Member Since
Mar 29, 2026
Posts
224
Likes Received
1,883
Location
Birmingham/Al
From a post in The Flying Purple Per Guild:

Over the last 2 months, the Crispy Testing Group gathered vials from 12 different batches of Uther's NAD+, spanning a 6 month course of time, and sent them off for endotoxin testing to Janoshik. This endeavor was prompted by the NA500-0113 batch which was tested at 984 EU/vial. As you know, this is a fairly high result which could be harmful at a high enough dosage of NAD+, and/or especially if injected alongside other peptides with moderate levels of endotoxin, and/or if taken by a lighter weight person.

The goal of the test was:

A) To see if any other batches around the 0113 timeframe had similarly high endo.

B) To see if there was a historical trend that could be gathered, since Uther freely disclosed that new raws were procured in Q4 and were being used to produce all his NAD+.

Below are the results in a graph and accompanying COAs. Its obvious that something changed in December so it may be a safe assumption to blame the new raws as the culprit. However we should be careful making definitive conclusions as this data only tells the what, not the why...

We look forward to any comments or additional information Uther may wish to share regarding these results, these batches or their products, as well batches not tested here and future NAD+ batches yet to be released.

One note you may have noticed, although we sent off 12 vials to be tested, one of them was damaged in shipping, so only 11 got tested with this round.

On behalf of our community, I give a hearty thanks to the contributors and donors of this the Crispy Testing Group, group test !

And lastly, these results CAN be shared. When we launched this test, we agreed all results would be freely available for everyone to use/share to allow those that purchased this NAD to make their own decisions on using their batches.

NA500-0912 : 12.7 EU/vial

https://verify.janoshik.com/tests/148664-NAD_XXBA5GKTIQPE

NA500-1101 : 11.3 EU/vial

Janoshik Analytical

NA500-1109 : 11.5 EU/vial

Janoshik Analytical

NA500-1210 : 602 EU/vial

https://verify.janoshik.com/tests/150380-NAD_500mg_VBF3VKRVZYRT

NA500-1216 : 657 EU/vial

https://verify.janoshik.com/tests/134363-Nad_Q5GHP2UHJZWQ

NA500-1224 : 1102 EU/vial (estimated)

https://verify.janoshik.com/tests/134364-NAD_68YCHQ5RTM3C

NA500-0113 : 1003 EU/vial (estimated)

h ttps://verify.janoshik.com/tests/134365-NAD_XYXAZ9CUCQF3

NA500-0115 : 1251 EU/Vail (estimated)

h ttps://verify.janoshik.com/tests/134366-NAD_5D5WS5P7RKPY

NA500-0122 : 889.3 EU/vial

h ttps://verify.janoshik.com/tests/134367-NAD_G4UGTPIRJYNS

NA500-0209 : 564.5 EU/vial

h ttps://verify.janoshik.com/tests/134368-NAD_7BV3BRMY2MKP

NA500-0306 : 737.5 EU/vial

h ttps://verify.janoshik.com/tests/134369-NAD_GV1B2SA61TNJ

NA500-1207 : Damaged / not tested

NOTE: Results >1000EU are estimated, not actual results.
 
When did he say he switched to the more expensive base materials to reduce endos? I thought it was in February. Not good.
 
Status
Not open for further replies.

Members online

No members online now.

Forum statistics

Threads
4,434
Messages
86,405
Members
7,877
Latest member
jhonpdr
Back
Top